WEKO3
アイテム
Costing analysis of field implementation of hepatitis C case detection in rural Maung Russey operational district, Cambodia
http://hdl.handle.net/10069/00041221
http://hdl.handle.net/10069/00041221fdb862ee-0cea-48ef-bbb1-244038505c69
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
WPSAR12_17.pdf (418.5 kB)
|
|
| Item type | 学術雑誌論文 / Journal Article(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2022-02-07 | |||||
| タイトル | ||||||
| タイトル | Costing analysis of field implementation of hepatitis C case detection in rural Maung Russey operational district, Cambodia | |||||
| 言語 | ||||||
| 言語 | eng | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | hepatitis C | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | screening | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | cost | |||||
| 資源タイプ | ||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
| 資源タイプ | journal article | |||||
| 著者 |
Han, Su Myat
× Han, Su Myat× Por, Ir× Samley, Keo× Bunreth, Voeurng× Smith, Chris× Ariyoshi, Koya× Dousset, Jean-Philippe× Le Paih, Mickeal |
|||||
| 抄録 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | Background: When a new health programme is introduced, it is crucial to estimate the costs for rational health policy decision-making. The aim of this study was to determine the costs of implementing two strategies for hepatitis C virus (HCV) screening in rural Cambodia. Methods: We retrospectively analysed clinical and cost data that were collected routinely for a demonstration project for scaling up HCV screening and testing in Cambodia. The programme data were collected between March and December 2018 in Maung Russey operational district in Battambang Province, Cambodia. Findings: During the study period, 24 230 people were screened; 1194 (5%) were HCV seropositive, of whom 793 (66%) were confirmed to be viraemic. During the study period, 18% of the estimated population of the operational district were screened, of whom 45% were estimated to be seropositive and 41% to be viraemic. With passive screening alone, 8% of the estimated population were screened, of whom 29% were estimated to be seropositive and 28% viraemic. The cost per detected viraemic case was US$ 194 for passive screening alone and US$ 283 for passive and active screening combined. Labour costs (31%) and tests and materials (29%) comprised the largest proportions of the cost. Conclusion: Combined active and passive screening per viraemic case detected was US$ 89 more expensive than passive screening alone but provided a higher yield (41% versus 28%) of viraemic cases. Therefore, adding active screening to passive screening is beneficial. Selective active screening strategies, such as targeting people over 45 years and other higher-risk groups, added value for HCV diagnosis. |
|||||
| 書誌情報 |
Western Pacific Surveillance and Response Journal 巻 12, 号 3, p. 17-24, 発行日 2021-07-12 |
|||||
| 出版者 | ||||||
| 出版者 | World Health Organization | |||||
| ISSN | ||||||
| 収録物識別子タイプ | ISSN | |||||
| 収録物識別子 | 20947321 | |||||
| DOI | ||||||
| 関連タイプ | isIdenticalTo | |||||
| 識別子タイプ | DOI | |||||
| 関連識別子 | 10.5365/wpsar.2020.11.3.006 | |||||
| 権利 | ||||||
| 権利情報 | © World Health Organization (WHO) 2021. Some rights reserved. The articles in this publication are published by the World Health Organization and contain contributions by individual authors. The articles are available under the Creative Commons Attribution 3.0 IGO license (CC BY 3.0 IGO http://creativecommons.org/licenses/by/3.0/igo/legalcode), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited. In any use of these articles, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. | |||||
| 著者版フラグ | ||||||
| 出版タイプ | VoR | |||||
| 出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
| 引用 | ||||||
| 内容記述タイプ | Other | |||||
| 内容記述 | Western Pacific surveillance and response journal : WPSAR, 12(3), pp.17-24; 2021 | |||||
